1. United Kingdom Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
Cambridge Nutritional Sciences plc

Cambridge Nutritional Sciences plc

CNSL.L
Cambridge Nutritional Sciences plcGB flagLondon Stock Exchange
1.81
GBp
-0.09
- -
4.31MMarket Cap
Cambridge Nutritional Sciences plc
CNSL.L
(London Stock Exchange)

Recent

price

1.81

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
0.34
0.2
0.13
0.13
0.11
0.11
0.12
0.13
0.07
0.07
0.07
0.04
0.05
0.03
0.04
0.04
Revenue per Share
0.01
- -
0.01
0.01
0.01
0.01
0.01
0.01
-0.06
0.01
-0.05
-0.01
-0.06
-0.02
- -
0.01
Basic EPS, GAAP
- -
-0.01
-0.01
-0.01
-0.01
-0.01
-0.01
-0.01
-0.03
-0.02
-0.01
-0.03
-0.03
-0.01
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.07
0.33
0.15
0.16
0.18
0.18
0.19
0.2
0.14
0.14
0.1
-0.01
-0.07
-0.07
-0.06
-0.06
Book Value per Share
0.03
0.09
0.05
0.04
0.07
0.06
0.06
0.05
0.02
0.01
0.03
0.08
0.04
0.02
0.02
0.03
Tangible Book Value per Share
18
39
86
86
105
110
110
110
123
129
142
172
183
231
238
238
Basic Weighted Avg Shares
6
8
11
11
12
12
13
14
8
9
10
7
9
8
10
8
Sales/Revenue/Turnover
4.76
1.73
4.65
2.72
4.55
5.56
5.26
4.88
-14.6
-3.1
7.15
-6.87
-6.93
-35.98
-5.47
-4.74
Operating Margin (%)
- -
- -
1
1
1
1
1
1
1
- -
1
1
1
1
1
1
Depreciation Expense
- -
- -
1
1
1
1
1
1
-7
1
-7
-2
-11
-4
- -
2
Net Income, GAAP
10.95
70.48
- -
- -
- -
- -
13.59
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
3.02
0.39
4.74
5.17
5.98
6.11
4.49
5.01
-87.28
11.13
-69.54
-30.87
-132.72
-51.15
-3.36
18.8
Profit Margin (%)
2
4
3
2
5
5
4
4
2
1
2
9
7
6
6
6
Working Capital
2
1
1
- -
- -
- -
- -
- -
1
- -
2
2
- -
- -
- -
- -
LT Debt
6
13
13
14
18
19
20
21
17
18
14
23
12
10
10
11
Total Equity
3.66
0.36
- -
- -
- -
- -
2.88
- -
- -
- -
- -
- -
- -
- -
- -
-3.69
Return on Invested Capital (%)
7.41
0.45
- -
- -
- -
- -
2.88
- -
- -
- -
- -
- -
- -
- -
- -
-11.14
Return on Capital (%)
18.74
0.44
4.01
4.27
4.25
3.87
2.85
3.39
-37.67
5.53
-42.99
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-0.38%
4.35%
17.84%
Free Cash Flow
32.82%
-22.05%
-180.11%
Net Income, GAAP
-239.68%
-73.09%
-577.44%
Sales/Revenue/Turnover
-0.94%
-0.43%
-14.77%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
10
2025
- -
- -
- -
- -
8
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
0.01
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Tetratherix Ltd. (TTX.AX)
Ortivus AB (publ) (ORTI-B.ST)
Tristel PLC (TSTL.L)
EssilorLuxottica S.A. (ESLOF)
IVF Hartmann Holding AG (0QQM.L)
Sector 10, Inc. (SECI)
Business
Cambridge Nutritional Sciences plc Cambridge Nutritional Sciences plc (AIM: CNSL) is a United Kingdom-based specialist medical diagnostics company that develops, manufactures, and distributes products focused on food sensitivity testing and gut health diagnostics; its core offerings include FoodPrint kits for detecting immune reactions to food via IgG antibody testing, the point-of-care Food Detective self-test kits, CNSLab functional testing services for healthcare professionals and consumers, the My Health Tracker app for symptom tracking and result management, and the newly launched Gut Detective stool biomarker panel assessing gut inflammation, enzyme production, and permeability. The company operates globally across more than 75 countries, serving over 170 laboratories, private clinics, nutritionists, naturopaths, and functional medicine practitioners in regions including the UK, Europe, North America, India, Asia, Africa, and the Middle East. Founded in 2004 and headquartered at Eden Research Park, Henry Crabb Road, Littleport, Cambridge, United Kingdom, the company rebranded from Omega Diagnostics Group PLC in September 2023 to emphasize its nutritional sciences focus. In recent developments, Cambridge Nutritional Sciences completed a sales team restructure in 2025 to separate customer acquisition, service, and success functions aimed at accelerating new distributor and laboratory signings amid slower sales cycles in Europe and the Americas; it launched the CE-marked Gut Detective product in August 2025 exclusively for the UK practitioner market initially; operational enhancements drove gross margins to 67.7% for the six months ended 30 September 2025 through improved FoodPrint production yields and product mix, despite a 6% revenue decline to £3.9 million; and the company invested in new manufacturing machinery, a Laboratory Information Management System upgrade, IVDR compliance development, and website enhancements while suspending new My Health Tracker app onboarding.